Abstract
Studies with glucose-6-phosphate dehydrogenase (G6PD) iso-enzymes have demonstrated that chronic myelogenous leukaemia (CML) is a clonal disorder of pluripotent haematopoietic stem cells which are capable of differentiation to myeloid cells, monocytes, erthrocytes and platelets1. It has been observed recently in G6PD heterozygous patients with chronic phase CML that the non-E-rosetting lymphocytes were restricted to a single enzyme type, indicating that some lymphoid cells must also arise from the leukaemic clone2. Surface or cytoplas-mic immunoglobulin could be detected in up to 46% of the cells of these isolated non-T-lymphocyte populations, which suggested that cells from the CML clone were capable of differentiating into B lymphocytes. To investigate this further, we established Epstein–Barr virus (EBV)-transformed B-lymphoblastoid cell lines derived from patients with CML and studied chromosomes and G6PD to determine whether progenitor B lymphocytes for any of the cell lines had originated from the CML clone. We report here direct evidence that immunoglobulin-synthesizing B lymphocytes can arise from the CML stem cell clone.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fialkow, P. J., Jacobson, R. J. & Papayannopoulou, T. Am J. Med. 63, 125–130 (1977).
Fialkow, P. J., Denman, A. M., Jacobson, R. J. & Lowenthal, M. N. J. clin. Invest. 62, 815–823 (1978).
Miller, G. & Lipman, M. Proc. natn. Acad. Sci. U.S.A. 70, 190–194 (1973).
Lozzio, C. B. & Lozzio, B. B. Blood 45, 321–334 (1975).
Minowada, J., Koshiba, H., Janossy, G., Greaves, M. F. & Bollum, F. J. Leukaemia Res. 3, 261–266 (1979).
Anderson, L. D., Jokinen, M. & Gahmberg, C. G. Nature 278, 364–365 (1979).
Hurley, J. N., Fu, S. M., Kunkel, H. G., Chaganti, R. S. K. & German, J. Nature 283, 76–78 (1980).
Lebien, T. W., Hozier, J., Minowada, J. & Kersey, J. H. New Engl. J. Med. 301, 144–147 (1979).
Vogler, L. B., Crist, W. M., Vinson, A. S., Brattain, M. G. & Coleman, M. S. Blood 54, 1164–1170 (1979).
Greaves, M. F. et al. Leukaemia Res. 3, 181–191 (1979).
Sumner, A. T., Evans, H. J. & Buckland, R. A. Nature new Biol. 232, 31–32 (1971).
Paris Conference: Standardization in Human Cytogenetics (The National Foundation—March of Dimes BD, OAS VIII, 1972).
Paris Conference (1971) & Suppl. (1975>) (The National Foundation-March of Dimes BD, OAS XI No. 9, 1975).
Hijmans, W., Schuit, H. J. R. & Klein, F. clin. exp. Immun. 4, 457–472 (1969).
Fialkow, P. J. Ann. hum. Genet. 37, 39–48 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martin, P., Najfeld, V., Hansen, J. et al. Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature 287, 49–50 (1980). https://doi.org/10.1038/287049a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/287049a0
This article is cited by
-
Imatinib independent aberrant methylation of NOV/CCN3 in chronic myelogenous leukemia patients: a mechanism upstream of BCR-ABL1 function?
Cell Communication and Signaling (2019)
-
Regulation of hematopoietic and leukemic stem cells by the immune system
Cell Death & Differentiation (2015)
-
Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium
Blood Cancer Journal (2011)
-
Insights into the stem cells of chronic myeloid leukemia
Leukemia (2010)
-
The history of myeloproliferative disorders: before and after Dameshek
Leukemia (2008)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
